Lymph node harvest in colon and rectal cancer: Current considerations.
Affiliation
Department of Surgery, The Christie NHS Foundation Trust, Manchester M20 4BX, United Kingdom.Issue Date
2012-01-27
Metadata
Show full item recordAbstract
The prognostic significance of identifying lymph node (LN) metastases following surgical resection for colon and rectal cancer is well recognized and is reflected in accurate staging of the disease. An established body of evidence exists, demonstrating an association between a higher total LN count and improved survival, particularly for node negative colon cancer. In node positive disease, however, the lymph node ratios may represent a better prognostic indicator, although the impact of this on clinical treatment has yet to be universally established. By extension, strategies to increase surgical node harvest and/or laboratory methods to increase LN yield seem logical and might improve cancer staging. However, debate prevails as to whether or not these extrapolations are clinically relevant, particularly when very high LN counts are sought. Current guidelines recommend a minimum of 12 nodes harvested as the standard of care, yet the evidence for such is questionable as it is unclear whether an increasing the LN count results in improved survival. Findings from modern treatments, including down-staging in rectal cancer using pre-operative chemoradiotherapy, paradoxically suggest that lower LN count, or indeed complete absence of LNs, are associated with improved survival; implying that using a specific number of LNs harvested as a measure of surgical quality is not always appropriate. The pursuit of a sufficient LN harvest represents good clinical practice; however, recent evidence shows that the exhaustive searching for very high LN yields may be unnecessary and has little influence on modern approaches to treatment.Citation
Lymph node harvest in colon and rectal cancer: Current considerations. 2012, 4 (1):9-19 World J Gastrointest SurgJournal
World Journal of Gastrointestinal SurgeryDOI
10.4240/wjgs.v4.i1.9PubMed ID
22347537Type
ArticleLanguage
enISSN
1948-9366ae974a485f413a2113503eed53cd6c53
10.4240/wjgs.v4.i1.9
Scopus Count
Collections
Related articles
- The re-evaluation of optimal lymph node yield in stage II right-sided colon cancer: is a minimum of 12 lymph nodes adequate?
- Authors: Cai Y, Cheng G, Lu X, Ju H, Zhu X
- Issue date: 2020 Apr
- Lymph node identification following neoadjuvant therapy in rectal cancer: A stage-stratified analysis using the surveillance, epidemiology, and end results (SEER)-medicare database.
- Authors: Ecker BL, Paulson EC, Datta J, Jeganathan AN, Aarons C, Kelz RR, Mahmoud NN
- Issue date: 2015 Sep
- Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
- Authors: Zeng WG, Zhou ZX, Wang Z, Liang JW, Hou HR, Zhou HT, Zhang XM, Hu JJ
- Issue date: 2014
- Lymph node count after preoperative radiotherapy is an independently prognostic factor for pathologically lymph node-negative patients with rectal cancer.
- Authors: Li Q, Zhuo C, Liang L, Zheng H, Li D, Cai S
- Issue date: 2015 Jan
- The number of retrieved lymph nodes needed for accurate staging differs based on the presence of preoperative chemoradiation for rectal cancer.
- Authors: Han J, Noh GT, Yeo SA, Cheong C, Cho MS, Hur H, Min BS, Lee KY, Kim NK
- Issue date: 2016 Sep